Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Issued: July 1987 Prosecuted by: Jerry Jannsen of Appleton, Wis.’ Wilhelm Law Service Litigated by: For Pfizer, New York’s Cadwalader, Wickersham & Taft. For Warner-Lambert, New York’s Skadden, Arps, Meagher, Slate & Flom and New York’s Wachtell, Lipton, Rosen & Katz Within six months of its March 1997 launch, Lipitor seized 20 percent of the share of the cholesterol drug market. That rapid commercial success — which translated into annual sales of $4.5 billion — would be enough to place the drug on any killer patent list. There’s more, however: Lipitor was essentially the engine that drove the merger between Pfizer Inc. and Warner-Lambert Company. Warner-Lambert, the patent holder, entered into a marketing agreement in 1997 with Pfizer. But in late 1999, Warner-Lambert announced a $66.8 billion merger with American Home Products Corp. of Madison, N.J. Fearful that this would derail the co-marketing agreement, Pfizer filed suit, claiming that the co-marketing agreement barred such a merger. Warner-Lambert countersued, seeking to end the co-marketing agreement. In January, Warner-Lambert agreed to be acquired by Pfizer for $90 billion. American Home Products walked away with a $1.8 billion breakup fee, but Pfizer won the Lipitor revenue sweepstakes.

This content has been archived. It is available exclusively through our partner LexisNexis®.

To view this content, please continue to Lexis Advance®.

Not a Lexis Advance® Subscriber? Subscribe Now

Why am I seeing this?

LexisNexis® is now the exclusive third party online distributor of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® customers will be able to access and use ALM's content by subscribing to the LexisNexis® services via Lexis Advance®. This includes content from the National Law Journal®, The American Lawyer®, Law Technology News®, The New York Law Journal® and Corporate Counsel®, as well as ALM's other newspapers, directories, legal treatises, published and unpublished court opinions, and other sources of legal information.

ALM's content plays a significant role in your work and research, and now through this alliance LexisNexis® will bring you access to an even more comprehensive collection of legal content.

For questions call 1-877-256-2472 or contact us at [email protected]


ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2020 ALM Media Properties, LLC. All Rights Reserved.